ABSTRACT Human fourth component of complement (C4) was found to be highly polymorphic by agarose gel electrophoresis of neuraminidase-treated plasma. The system allows clear-cut separation of the products of the two C4 genetic loci, C4A (acidic or Rodgers) and C4B (basic or Chido). There are at least six structural variants and a deletion allele at the CM4 locus and two structural variants and a deletion allele at the C4B locus. Close linkage with no crossovers was found between the two C4 loci, allowing the definition of C4AB haplotypes, and between C4 haplotypes and the C2 and BFloci of the human histocompatibility complex. Nine C4 haplotypes, each with a frequency of 0.005 or more in Caucasians, were found. These studies provide direct evidence for two distinct but closely linked genetic loci for human C4 in the major histocompatibility complex on the short arm of chromosome 6.
An accurate description of the genetics of the fourth component of complement (C4) is important because the C4 genetic loci appear to be closely linked to the major histocompatibility complex (MHC) in man. This is particularly true if genetic loci for immune responsiveness in man are in this region and if variants of the latter loci are determinants of human disease. A number of diseases show striking linkage disequilibrium with specific HLA types (1), and recent evidence strongly suggests that BF (the locus for factor B of the alternative complement pathway in the MHC) is closely linked to a genetic locus for insulin-dependent diabetes mellitus (2) .
In their study of structural polymorphism of human C4, Rosenfeld et al. (3) used prolonged agarose gel electrophoresis and antiserum to C4 to define patterns in plasma or serum containing EDTA. They noted differences in patterns from person to person but were unable to construct a simple genetic model to explain these differences in populations or in families.
Teisberg et al. (4) used similar electrophoretic methods to define one rare and two common C4 structural alleles at a single genetic locus. Mauff (5) introduced a discontinuous buffer system that produced discrete C4 bands, and this was then used to describe two common and two rare variants at a single locus (5, 6) . Teisberg et al. (7) used a discontinuous buffer similar to Mauff's to redefine their alleles and gene frequencies. There was a lack of correspondence, in general, among the variants postulated by each group or their gene frequencies. Mauff et al. (6) pointed out that the population distribution of these postulated C4 variants at a single locus just barely fits the Hardy-Weinberg equilibrium, whereas the fit is excellent for other serum protein genetic systems.
O'Neill et al. (8) made the important observation that, by similar discontinuous electrophoretic techniques, C4 patterns in most of the population formed eight bands, whereas in about 5% only the four fast (C4F) bands were present and in about 2% only the slow (C4S) bands were found. They concluded that C4F and C4S could not be produced by alleles at a single locus but rather that they represented products of two distinct but closely linked loci. Furthermore, sera from "half-null" homozygotes that lacked C4F were negative for the "blood group"
antigen Rodgers [Rg(a-)l and those that lacked C4S were negative for Chido [Ch(a-)]. The 93% of random serum samples that had both C4F and C4S were Ch(a+) and Rg(a+). These workers further postulated (9) that deficiencies or null alleles at either the C4F or C4S locus were common. Simple examination of C4 patterns produced in their system, however, did not reveal the expected number of heterozygotes for the half-null haplotypes and C4FS (10) . In subsequent publications, Olaisen et al. (11, 12) conceded that some chromosomes carried two C4 loci and others carried only one, and they revised their genetic model, the number of alleles and haplotypes, and their frequencies accordingly.
Despite the differences in the postulated number, character, and frequency of alleles and number of loci of human C4, all workers are remarkably agreed that the gene(s) controlling C4 synthesis are closely linked to HLA. Although there are obvious problems in determining heterozygotes for C4 deficiency, evidence from families of individuals who completely lack C4 (13, 14) suggests close linkage of this deficiency state with HLA and with the other complement genetic loci of the MHC, C2 and BF. The fact that Chido and Rodgers are carried on C4 molecules allows one to conclude that the C4 structural loci are probably MHC-linked, because Chido and Rodgers are determined by.genes in this region (15, 16) .
Recently, we (17) showed that crossed immunoelectrophoresis of neuraminidase-treated C4 in whole plasma allowed the detection in heterozygotes of the half-null haplotypes, deficient in either C4F or C4S, postulated by O'Neill et al (8) . In half-null haplotypes as described (17) and to immunofixation electrophoresis in 0.75% agarose (ICN) using a Tris/glycine/ barbital discontinuous buffer system (8) .
Desialated plasma samples (5 gl) were applied to 10 X 20 X 0.1 cm agarose gels. Electrophoresis was carried out on a cooled plate (circulating water bath) at 30 V/cm for 6 hr. by which time a human Hb S marker band had migrated 8 cm. C4 was visualized by layering 1 ml of goat anti-human C4 antiserum (Atlantic Antibodies, Scarborough, ME) evenly over the plate. After 3 hr of incubation in a humid chamber at room temperature, the plates were pressed with absorbent paper, washed three times for 1 hr in isotonic saline, dried, and stained with 0.25% Coomassie brilliant blue in methanol/water/acetic acid, 45:45:10 (vol/vol). Some plates were not immunofixed but were developed with a C4 functional overlay consisting of 1% sheep erythrocytes optimally sensitized with rabbit antibody in 0.6% agarose in barbital-buffered saline with Ca2+, Mg2+ (18), and 5% hydrazine-treated normal or C4-deficient guinea pig serum. For comparison, untreated plasma samples were analyzed by agarose electrophoresis as described (8) .
BF and C2 Typing. Plasma samples were subjected to agarose gel electrophoresis and immunofixation for BF typing as described (19) and to isoelectric focusing in thin-layer polyacrylamide gels (20) as described (18) except that normal human serum at a 1:90 dilution was used instead of C2-deficient serum in the overlay.
Nomenclature. The nomenclature for genetic polymorphism of human C4 proposed in this paper is designed to conform to the recently formulated "International System for Human Gene Nomenclature." To avoid confusion with previously described C4 forms which have no correspondence to those of the present report, the locus controlling the more acidic group of Rodgers-positive [Rg(a+)] variants is designated C4A and that controlling the more basic Chido-positive [Ch(a+)] variants is designated C4B. The variants at each locus have arbitrarily been numbered with integers according to the electrophoretic mobility of the desialated proteins at pH 8.8, from cathode to anode. Numbering of new variants should continue in order of discovery or naming. Individual alleles are italicized and des- ignated: locus name, an asterisk, and a number or the symbol "QO" if null (e.g., C4A*2, C4B*QO, and C4B*1). Phenotypes or proteins are designated in Roman capitals with a space between locus symbol and variant (e.g., C4A 4, C4B 2, and C4B QO). Haplotypes are written as follows: C4A*2 C4B*1/C4A*l C4B*1, C4A*2 C4B*QO/C4A*2 C4B*1, etc. To save space in text or tables, these have been shortened to A2Bl/A1Bl, A2BQO/A2B1, etc. A preliminary report of the present findings (21) used a nomenclature similar to the one presented here, but the C4A variants in that report did not include C4A*1 or C4A*5 as described here. The nomenclature here takes these into ac-
count. RESULTS
The common C4 patterns produced from electrophoresis of neuraminidase-treated plasma samples and immunofixation with anti-C4 are shown in Fig. 1 Right. For comparison, the C4 patterns produced by the same samples not treated with neuraminidase are shown in Fig. 1 Left. It is clear that neuraminidase treatment results in resolution of two areas (C4A and C4B) that partially overlap in the electrophoretic patterns (Fig. 2) . A means for distinguishing C4A from C4B products involves functional development of patterns. When C4 patterns were developed by a C4-sensitive hemolytic overlay, the neuraminidase-treated samples showed almost exclusively C4B types (Fig. 3) . Several individuals whose plasma or serum was Ch(a-) produced no major bands of hemolysis, whereas Rg(a-) samples always produced patterns that were C4B 1, C4B 1,2, or C4B 2. Bands of hemolysis corresponding to C4A types could be produced by decreasing the number of sensitized erythrocytes in the overlay and increasing the development time for hemolytic pattern development. This frequencies in randomly selected Caucasians (Table 4) . From the 58 C4 haplotypes generated in this manner, frequencies for C4A and C4B types individually were determined and compared with those obtained directly from phenotypes from the random donors (Tables 1 and 2 ). The correspondence was good. One haplotype, C4A*1 C4B*1, contained a C4A variant not uncovered in the study of the 100 randoms; C4A*5 was not in the 22 families studied. Evidence for linkage between the C4 haplotypes and BF and C2 was sought. For C4-BF there were 46 informative meioses and no crossovers (lod at 0 = 0.0001 was 10.8). Similarly, no C4-C2 crossovers were seen among 14 informative meioses (lod at 0 = 0.0001 was 3.9).
DISCUSSION
It is clear from the results of the present study that C4 in man displays a richness of inherited structural variation that is impressive, even for a protein produced by a gene in a chromosomal region characterized by extensive polymorphism. Although this was suspected from the outset, attempts to delineate variants and define a genetic system in terms of a single locus were bound to be frustrated. The postulation by O'Neill and his colleagues (8, 9) of two closely linked loci producing C4 in man and the demonstration that the "red cell antigen" Chido marked one and Rodgers antigen marked the other of these two loci were keys to further understanding of C4 genetics. Another key was the postulation of common half-null C4 haplotypes by this same group.
The remaining problems were technical. It was not possible to detect the half-null haplotypes in heterozygotes reliably by the previous electrophoretic system, even with a discontinuous buffer (5). This difficulty was circumvented by desialation of C4 in whole plasma or serum and crossed immunoelectrophoresis with anti-C4 (17) . It thus became possible to distinguish the complete from the half-null C4 haplotypes in individuals and families. Desialation allowed fairly complete electrophoretic separation of the products of the two C4 loci and the possibility of reliably defining structural variants at each C4 locus. The findings of the present study provide direct confirmation of the two-locus model by showing that some individuals carry four structural variants of C4.
Comparison of the C4A and C4B gene frequencies of Table  1 with the C4AB haplotype frequencies given in Table 4 shows that marked linkage disequilibrium occurs between specific alleles of C4A and C4B. For example, every instance of C4B*QO is found in linkage disequilibrium with C4A*3, and the ratio of the haplotypes C4A*QO C4B*2 to C4A*QO C4B*1 is 1 rather than 0.14 as predicted if the alleles were associated randomly.
The recent attempt to convert a one-locus genetic model of human C4 (4, 7) into a part one-locus, part two-locus model (11, 12) by stating that the C4 locus is duplicated on some chromosomes ignores certain facts. Ch and Rg (C4B and C4A) are not allelic (22) . C4 of each type differs antigenically, functionally [as shown here and as suggested earlier (3)], and by multiple surface charges shown here to reside in the desialated proteins. Thus, persons who have only a C4A variant on one chromosome and a C4B variant on the other express only a single C4 gene on each chromosome, yet the loci are different from each other. In other words, duplication of the C4 locus had to precede deletion in the distant past. Because the present study has demonstrated the existence of a number of C4A variants that occur in the test population only in duplicated form (C4A*6 C4B*1 and C4A*4 C4B*2, for example) but not in single form, this is further evidence that the duplicated forms preceded the currently observed single-locus forms. Another way of looking at this same evidence is to note that C4B*QO occurs in our test population only in linkage disequilibrium with C4A*3 and not with C4A*1, 2, 4, 5, or 6.
Such a series of events has been postulated for the two closely linked loci for a-globin in man (23) . The silent carrier state for a-thalassemia is common in blacks and has recently been shown to involve half-null haplotypes with the DNA of one a-globin chain gene deleted (24) . Deletion is thought to occur from nonhomologous pairing of the first a-globin gene on one Genetics: Awdeh and Alper 3580 Genetics: Awdeh and Alper chromosome at meiosis with the second (very similar) gene on its paired chromosome. This then could lead to unequal crossing over and production of a half-null (and a triplicated) haplotype. Furthermore, just as with the silent a-thalassemia trait of the blacks, half-null haplotypes of C4 would not be expected to be deleterious to the host because no combination would result in less than 50% of the C4 level of individuals with four structural genes.
The difference in function between the products of C4A and C4B can be seen in retrospect in the data of Rosenfeld et al. (3) , on the assumption that pattern 2 in their nomenclature had only type A C4 and pattern S had only type B C4. In our study, under the nonquantitative conditions of the functional overlay, only C4B products had significant activity. This is at least partly due to instability of C4 of type A during the incubation with neuraminidase.
Tandem duplication of the C4 (Ss) genetic locus in the mouse may have led to the generation of Slp. Slp shows antigenic crossreactivity (25) and considerable structural homology to C4 (26, 27) in the mouse but has no C4 hemolytic activity (27) . On the other hand, the available evidence suggests that a single locus controls C4 in the guinea pig (28) .
The absence of detectable crossovers between the two C4 loci is in keeping with C4A and C4B being closely linked and perhaps immediately contiguous, as suggested by O'Neill and coworkers. The absence of detectable crossovers between either C4 locus and either BF or C2 is firm evidence that the structural genes for C4 in man are closely linked to the MHC on the short arm of chromosome 6. The strongest previous evidence for very close linkage between C4 and the MHC in man was derived from the study of Ch(a-) and Rg(a-) individuals and their families (15, 16) and depends on these antigenic determinants being coded for by the two C4 loci (8) . Far less convincing is the evidence from C4-deficient patients and their families (13, 14) Although previous typing systems were not capable of defining C4 types accurately, it is likely that, of all the common C4A types, C4A 6 was recognized in some samples, particularly in combination with C4A QO. Most likely it is the C4A1 of Rosenfeld et al. (3) , the C4F1 of Mauff (5, 6) , and the C4D of Olaisen et al. (11, 12) .
The alleles and haplotypes of C4 described in this report predict 168 possible C4A-B phenotypes and 21 C4 haplotypes. Of these, some predicted phenotypes have not yet been observed, possibly because of the relatively small number of samples examined so far. It is highly likely that additional C4 haplotypes involving new alleles at either the C4A or C4B locus or new combinations of known alleles will be found, and these may occur at appreciable frequencies. For similar reasons, allele and haplotype frequencies given in this report are merely approximations, and more accurate estimates will only come from the study of very large numbers of families for haplotypes and populations for alleles.
